Mutation or loss of DNA damage repair genes, such as BRCA1/2 can lead to genomic instability, the onset of cancer, and can facilitate the development of resistance to DNA-damaging chemotherapy. Our lab is investigating novel drug interventions which may improve the outcome for patients with DNA repair defects
Novel treatment strategies for DNA damage repair-deficient tumours
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.